Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal FADS1 Primary Antibody for ELISA, WB - ABIN188723
Cho, Nakamura, Clarke: Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. in The Journal of biological chemistry 2000
The results of this population-based study provide evidence for a relationship between lipid regulatory gene polymorphisms including GCKR (show GCKR Antibodies) (rs780094), GCKR (show GCKR Antibodies) (rs1260333), FADS (rs174547), and MLXIPL (show MLXIPL Antibodies) (rs3812316) with dyslipidemia in an Iranian population.
An association was found between the rs174550 FADS1 polymorphism and gestational diabetes mellitus risk.
commonly overexpressed COX (show COX8A Antibodies) in cancer (~90% of colon cancer patients) can be taken advantage to suppress cell growth by knocking down delta-5-desaturase (D5D, a key enzyme that converts DGLA to arachidonic acid). In addition, D5D knockdown along with DGLA supplement may enhance the efficacy of chemotherapeutic drugs
In minor allele carriers of FADS1 and FADS2 (show FADS2 Antibodies), plasma arachidonic acid (ARA (show FOXC1 Antibodies)) content was elevated only at the highest level of ARA (show FOXC1 Antibodies) consumed in infant formula. ARA (show FOXC1 Antibodies) level in plasma is reduced by low ARA (show FOXC1 Antibodies) consumption and by minor alleles in FADS in infants fed ARA (show FOXC1 Antibodies)-containing formula.
D5D knockdown in conjunction with dihomo-gamma-linolenic acid treatment can also be used to inhibit growth of pancreatic cancer cells via p53 (show TP53 Antibodies) independent pathway.
Our results showed that knockdown of delta-5-desaturase along with DGLA supplement not only significantly inhibited cell migration, but also improved the efficacies of 5-flurouracil and gemcitabine, two frontline chemotherapy drugs currently used in the treatment of colon and pancreatic cancer.
The majority of CpG sites (117 out of 136, 86%) exhibited high levels of methylation with the greatest variability observed at three key regulatory regions-the promoter regions for FADS1 and FADS2 (show FADS2 Antibodies) and a putative enhancer site between the two genes.
FADS1 rs174547 and FADS2 (show FADS2 Antibodies) rs2727270 genotypes were significantly correlated with decreased HDL (show HSD11B1 Antibodies)-C concentrations, and D5D /D6D (show FADS2 Antibodies) activities as estimated as 20:4(n-6)/20:3 (n-6) and 18:3 (n-6)/18:2 (n-6) in a linear pattern in patients with type 2 diabetes
Results indicate that genetic variation in the FADS1 gene, rs174546, influences blood pressure via arachidonic acid and body mass index. Thus, polymorphisms with an impact on the delta-5 desaturase activity may play a role for the blood pressure level mediated through polyunsaturated fatty acids and body mass index.
FADS1 rs174549 polymorphism and fish consumption may be protective factors for oral cancer, with a gene-diet multiplicative interaction
Data (including data from studies using knockout mice) suggest that increased dietary intake of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) differentially affects activity of D5D/Fads1 and D6D/Fads2 (show FADS2 Antibodies) in specific tissues.
differential PUFA profiles between HET mice and human FADS SNPs suggest low expression of both FADS1 and 2 genes in human minor haplotypes.
Data indicate that delta-5 desaturase (D5D) inhibition was confirmed by determining changes in blood arachidonic acid/dihomo-gamma-linolenic acid (AA/DGLA) profiles.
knockdown of Elovl5 (show ELOVL5 Antibodies), Fads1, or Fads2 (show FADS2 Antibodies) decreased the level of Mead acid.
The Systemic disruption of the Fads1 gene reciprocally altered the levels of dihomo-gamma-linolenic acid and AA in mouse tissues, resulting in a profound increase in 1-series-derived and a concurrent decrease in 2-series-derived prostaglandins.
analysis of mRNA abundance and expression of SLC27A, ACC, SCD, FADS, LPIN, INSIG, and PPARGC1 gene isoforms in mouse mammary glands during the lactation cycle
n-3 fatty acid desaturase (show SCD Antibodies) may have a role in colitis-associated colon cancer in mice
The protein encoded by this gene is a member of the fatty acid desaturase (FADS) gene family. Desaturase enzymes regulate unsaturation of fatty acids through the introduction of double bonds between defined carbons of the fatty acyl chain. FADS family members are considered fusion products composed of an N-terminal cytochrome b5-like domain and a C-terminal multiple membrane-spanning desaturase portion, both of which are characterized by conserved histidine motifs. This gene is clustered with family members FADS1 and FADS2 at 11q12-q13.1\; this cluster is thought to have arisen evolutionarily from gene duplication based on its similar exon/intron organization.
, delta(5) fatty acid desaturase
, delta-5 desaturase
, delta-5 fatty acid desaturase
, linoleoyl-CoA desaturase (delta-6-desaturase)-like 1
, fatty acid desaturase 1